Who has invested in Kyverna Therapeutics?

Northpond Ventures are named among the investors backing Kyverna Therapeutics.

Kyverna Therapeutics Funding: $170M Raised, Series B (2023)

Kyverna Therapeutics funding overview

Kyverna Therapeutics is based in Emeryville, California. Kyverna Therapeutics has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for Kyverna Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Northpond Ventures.

Kyverna Therapeutics at a glance

Total raised: $170M
Latest round: Series B
Latest round date: January 2023
Headquarters: Emeryville, California
Notable investors: Northpond Ventures

Frequently asked about Kyverna Therapeutics funding

How much has Kyverna Therapeutics raised?: Kyverna Therapeutics has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Kyverna Therapeutics?: Northpond Ventures are named among the investors backing Kyverna Therapeutics.
What was the latest Kyverna Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2023.
Where is Kyverna Therapeutics based?: Kyverna Therapeutics is based in Emeryville, California.
When did Kyverna Therapeutics last raise?: The last disclosed Kyverna Therapeutics round closed in January 2023 at Series B.

We update the Kyverna Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Emeryville and their backers are listed below.

Kyverna Therapeutics Funding: $170M Raised, Series B (2023)

Kyverna Therapeutics funding overview

Kyverna Therapeutics at a glance

Frequently asked about Kyverna Therapeutics funding

Companies related to Kyverna Therapeutics (35)

Browse related funding lists (4)